PIASy, a nuclear matrix-associated SUMO E3 ligase, represses LEF1 activity by sequestration into nuclear bodies

Genes and Development

Volumn 15, Issue 23, 2001, Pages 3088-3103

  Sachdev, Shrikesh ^a   Bruhn, Laurakay ^a   Sieber, Heidemarie ^a   Pichler, Andrea ^b   Melchior, Frauke ^b   Grosschedl, Rudolf ^a  

^a UNIVERSITY OF MUNICH   (Germany)

^b MAX PLANCK INSTITUTE OF BIOCHEMISTRY   (Germany)

Author keywords

LEF1 TCF; Nuclear matrix; PIAS; PML bodies; SUMO

Indexed keywords

BETA CATENIN; LYMPHOID ENHANCER FACTOR 1; PROTEIN; PROTEIN INHIBITOR; PROTEIN INHIBITOR OF ACTIVATED STAT; SMALL UBIQUITIN RELATED MODIFIER; STAT PROTEIN; TRANSCRIPTION FACTOR; UNCLASSIFIED DRUG; WNT PROTEIN;

ANIMAL CELL; ARTICLE; CELL NUCLEUS INCLUSION BODY; CELL NUCLEUS MATRIX; CONTROLLED STUDY; DNA SEQUENCE; NONHUMAN; PRIORITY JOURNAL; PROTEIN BINDING; PROTEIN EXPRESSION; PROTEIN INTERACTION; PROTEIN MODIFICATION; REGULATORY MECHANISM;

ANIMALS; CARRIER PROTEINS; CELL LINE; CHROMOSOMES; DNA; DNA-BINDING PROTEINS; ELECTROPHORETIC MOBILITY SHIFT ASSAY; FLUORESCENT ANTIBODY TECHNIQUE; GENE EXPRESSION REGULATION; HUMANS; INTRACELLULAR SIGNALING PEPTIDES AND PROTEINS; LIGASES; LYMPHOID ENHANCER-BINDING FACTOR 1; MICE; MICROSCOPY, CONFOCAL; MUTAGENESIS, SITE-DIRECTED; NUCLEAR MATRIX; ORGANELLES; PROTEIN BINDING; PROTEIN INHIBITORS OF ACTIVATED STAT; PROTEIN TRANSPORT; SIGNAL TRANSDUCTION; SMALL UBIQUITIN-RELATED MODIFIER PROTEINS; TRANSCRIPTION FACTORS; TRANSCRIPTION, GENETIC; TWO-HYBRID SYSTEM TECHNIQUES; UBIQUITIN-PROTEIN LIGASES;

ANIMALIA;

EID: 0035576878     PISSN: 08909369     EISSN: None     Source Type: Journal    
DOI: 10.1101/gad.944801     Document Type: Article

References (73)

1. aSAP: A putative DNA-binding motif involved in chromosomal organization
2. Expression and regulation of the mammalian SUMO-1 E1 enzyme
3. A Drosophila PIAS homologue negatively regulates stat92E
4. Linking colorectal cancer to Wnt signaling
5. Biological significance of unwinding capability of nuclear matrix-associating DNAs
6. The transcription coactivator CBP is a dynamic component of the promyelocytic leukemia nuclear body
7. Association of transcriptionally silent genes with Ikaros complexes at centrometic heterochromatin
8. ALY, a context-dependent coactivator of LEF-1 and AML-1, is required for TCRα enhancer function
9. Wnt signaling: A common theme in animal development
10. Intranuclear relocalization of matrix binding sites during T cell activation detected by amplified fluorescence in situ hybridization
11. Posttranslational modification of TEL and TEL/AML1 by SUMO-1 and cell-cycle-dependent assembly into nuclear bodies
12. The PML gene encodes a phosphoprotein associated with the nuclear matrix
13. Specific inhibition of Stat3 signal transduction by PIAS3
14. Chromosome territories, nuclear architecture and gene regulation in mammalian cells
15. The PML-RAR fusion mRNA generated by the t(15;17) translocation in acute promyelocytic leukemia encodes a functionally altered RAR
16. A novel macromolecular structure is a target of the promyelocytic-retinoic acid receptor oncoprotein
17. Regulation of LEF-1/TCF transcription factors by Wnt and other signals
18. Cell cycle regulation of PML modificaton and ND 10 composition
19. Regulation of p53 activity in nuclear bodies by a specific PML isoform
20. LEF-1 contains an activation domain that stimulates transcription only in a specific context of factor binding sites
21. Assembly and function of a TCRα enhancer complex is dependent on LEF-1-induced DNA bending and multiple protein-protein interactions
22. Distinct effects of PIAS proteins on androgen-mediated gene activation in prostate cancer cells
23. The Drosophila Su(var) 2-10 locus regulates chromosome structure and function and encodes a member of the PIAS protein family
24. PODs in the nuclear spot: Enigmas in the magician's pot
25. Protein modification by SUMO
26. The ubiquitin system
27. Modulation of transcriptional regulation by LEF-1 in response to Wnt-1 signaling and association with β-catenin
28. Transcriptional regulation of the interleukin-2 gene in normal human peripheral blood T cells: Convergence of costimulatory signals and differences from transformed T cells
29. The lore of the RINGs: Substrate recognition and catalysis by ubiquitin ligases
30. RING finger proteins: Mediators of ubiquitin ligase activity
31. Ubc9p is the conjugating enzyme for the ubiquitin-like protein Smt3p
32. An E3-like factor that promotes SUMO conjugation to the yeast septins
33. The ubiquitin-like protein Smt3p is activated for conjugation to other proteins by an Aos1p/Uba2p heterodimer
34. Involvement of PIAS1 in the sumoylation of tumor suppressor p53
35. Chromosomal translocation t(15;17) in human acute promyelocytic leukemia fuses RAR with a novel putative transcription factor
36. Role of PML and PML-RARα in Madmediated transcriptional repression
37. SAFBox, a conserved protein domain that specifically recognizes scaffold attachment region DNA
38. ARIP3 (androgen receptor-interacting protein 3) and other PIAS (protein inhibitor of activated STAT) proteins differ in their ability to modulate steroid receptor-dependent transcriptional activation
39. Functional analysis and intracellular localization of p53 modified by SUMO-1
40. Role of promyelocytic leukemia (PML) sumolation in nuclear body formation, 11S proteasome recruitment, and As203-induced PML or PML/retinoic acid receptor α degradation
41. Structure and function of the nucleus
42. Chromatin components as part of a putative transcriptional repressing complex
43. Transcriptional repression by AML1 and LEF-1 is mediated by the TLE/Gr corepressors
44. Sequestration and inhibition of Daxx-mediated transcriptional repression by PML
45. Inhibition of Stat1-mediated gene activation by PIAS1
46. A transcriptional corepressor of Statl with an essential LXXLL signature motif
47. Distinct roles for P-CREB and LEF-1 in TCRα enhancer assembly and activation on chromatin templates in vitro
48. SUMO-nonclassical ubiquitin
49. Covalent modification of p73alpha by SUMO-1: Two-hybrid screening with p73 identifies novel -SUMO-1-interacting proteins and a SUMO-1 interaction motif
50. Conjugation with the ubiquitin-related modifier SUMO-1 regulates the partitioning of PML within the nucleus
51. SUMO, ubiquitin's mysterious cousin
52. A putative protein inhibitor of activated STAT (PIASy) interacts with p53 and inhibits p53-mediated transactivation but not apoptosis
53. Rb targets histone H3 methylaton and HP1 to promoters
54. Interaction between Wnt and TGF-α signalling pathways during formation of Spemann's organizer
55. SUMO-1 conjugation in vivo requires both a consensus modification motif and nuclear targeting
56. The Xenopus Wnt effector XTcf-3 interacts with Groucho-related transcript repressors
57. Ubc9p and the onjugation of SUMO-1 to RanGAP1 and RanBP2
58. The small ubiquitin-like modifier-1 (SUMO-1) consensus sequence mediates Ubc9 binding and is essential for SUMO-1 modification
59. The PML nuclear bodies: Actors or extras?
60. Interaction of SP100 with HP1 proteins: A link between the promyelocytic leukemia-associated nuclear bodies and the chromatin compartment
61. Common properties of nuclear body protein SP100 and TIF1α chromatin factor: Role of SUMO modification
62. Macromolecular domains within the cell nucleus
63. Intracellular receptors use a common mechanism to interpret signaling information at response elements
64. The promyelocytic leukemia protein interacts with Sp1 and inhibits its transactivaton of the epidermal growth factor promoter
65. Armadillo coactivates transcription driven by the product of the Drosophila polarity gene dTCF
66. Role of PML in cell growth and the retinoic acid pathway
67. The growth suppressor PML represses transcription by functionally and physically interacting with histone deacetylases
68. Trichostatin and leptomycin: Inhibition of histone deacetylation and signal dependent nuclear export
69. Dynamic relocation of transcription and splicing factors dependent upon transcriptional activity
70. The transcriptional role of PML and the nuclear body
71. Regulation of matrix attachment region-dependent, lymphocyte-restricted transcription through differential localization within promyelocytic leukemia nuclear bodies